Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
James E. Flynn - 21 Feb 2025 SCHEDULE 13D/A Report for Singular Genomics Systems, Inc. Common Stock, par value $0.0001 per share (OMIC)
- Filing manager
- James E. Flynn
- Reporting owner
- Deerfield Mgmt IV, L.P.
- Beneficially owned shares
- 1,000 shares
- Large-stake signal
-
Ownership
100%Beneficial ownership of this reported class.
Shares
1,000 sharesShares beneficially owned as disclosed.
Event date
21 Feb 2025Date tied to the ownership event or amendment.
Accepted by SEC
25 Feb 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 100%
- Symbol
- OMIC
- Shares outstanding
- 1,000 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 25 Feb 2025, 21:18:06 UTC
- Event date
- 21 Feb 2025
- Prior SEC filing
- 26 Dec 2024
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
James E. Flynn disclosed 100% ownership in Singular Genomics Systems, Inc. Common Stock, par value $0.0001 per share (OMIC) on 21 Feb 2025.
Key facts
- James E. Flynn filed SCHEDULE 13D/A for Singular Genomics Systems, Inc. Common Stock, par value $0.0001 per share (OMIC).
- Disclosed ownership: 100%.
- Date of event: 21 Feb 2025.
Change
- Previous schedule filing date: 26 Dec 2024.
- Current filing was accepted on 25 Feb 2025, 21:18.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (4)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deerfield Mgmt IV, L.P. | 100% | 1,000 | 0 | 1,000 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001713467 |
| Deerfield Private Design Fund IV, L.P. | 100% | 1,000 | 0 | 1,000 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001680307 |
| Deerfield Management Company, L.P. | 100% | 1,000 | 0 | 1,000 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001009258 |
| James E. Flynn | 100% | 1,000 | 0 | 1,000 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001352546 |
CIK / CUSIP context first